Actual Medicinal Product (AMP) Imigran Radis 100mg tablets (Abacus Medicine Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
No special storage requirements.
- Provenance
-
This compatibility recommendation is derived from Imigran Radis 100mg tablets (GlaxoSmithKline UK Ltd), Imigran 100mg tablets (GlaxoSmithKline UK Ltd) and generic sumatriptan 100mg tablets.
- Generic
- Sumatriptan
- Formulation
- Sumatriptan 100mg tablets
-
Sumatriptan
-
Sumatriptan 100mg tablets
-
Imigran Radis 100mg tablets (Abacus Medicine Ltd)
-
-